Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Por un escritor de hombre misterioso
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies, Cell & Bioscience
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies - Xie - iMeta - Wiley Online Library
Frontiers Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
Frontiers Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Cancers, Free Full-Text
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies, Cell & Bioscience
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
T-cell engineering strategies for tumors with low antigen density, and T- cell survival in the immunosuppressive tumor microenvironment of relapsed/refractory diffuse large B-cell lymphoma – ScienceOpen
PDF) CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies